EP
ORTX

Eversept Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Eversept Partners’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-41,958
Closed -$299K – 102
2022
Q1 		$299K Hold
41,958
– – 0.02% 84
2021
Q4 		$554K Sell
41,958
-15,000
-26% -$248K 0.04% 98
2021
Q3 		$1.31M Buy
+56,958
New +$1.69M 0.09% 88

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Eversept Partners's ORTX Position: Q2 2022 in Review

Eversept Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 41,958 shares — an estimated $299K sold.

Eversept Partners first reported a position in ORTX in Q3 2021 and held it in 3 quarters. The position peaked at $1.31M in Q3 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • Eversept Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 41,958 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $299K.
  • Eversept Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Eversept Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $1.31M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.